Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension [PDF]
, 2017 Fiona Gupta +2 more
openalex +1 more source
Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease [PDF]
, 2017 Daniel O. Claassen, Mark Lew
openalex +1 more source
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients [PDF]
, 2018 Katherine E. McDonell +7 more
openalex +1 more source
Voltammetric Determination of Droxidopa in the Presence of Tryptophan Using a Nanostructured Base Electrochemical Sensor [PDF]
, 2019 Halimeh Yaghoubian +5 more
openalex +1 more source
Stability-Indicating Related Substances HPLC Method for Droxidopa and Characterization of Related Substances Using LC–MS and NMR [PDF]
, 2016 T. Hemant Kumar +2 more
openalex +1 more source
Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease [PDF]
, 2018 Robert A. Hauser +3 more
openalex +1 more source
774: USE OF DROXIDOPA FOR HEMODYNAMIC SUPPORT AND VASOPRESSOR WEANING IN THE INTENSIVE CARE UNIT
Critical Care Medicine, 2022 M. Noble +2 more
semanticscholar +1 more source
Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension [PDF]
, 2018 Satish R. Raj, L. Arthur Hewitt
openalex +1 more source
Accidental Overdose of Droxidopa in Parkinson's Disease‐related Orthostatic Hypotension [PDF]
, 2016 Addie Patterson, Christopher W. Hess
openalex +1 more source